Log In
BCIQ
Print this Print this
 

SYD001

  Manage Alerts
Collapse Summary General Information
Company Synovo GmbH
DescriptionSmall molecule that modulates the production of proinflammatory cytokines
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat chronic inflammatory bowel disease (IBD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today